Sign In
Get Clay Free →

Suggestions

    Petra Rupar

    Policy, Access & Reputation Strategy Lead at Roche

    Professional Background

    Petra Rupar is an esteemed professional in the pharmaceutical industry, currently serving as the Policy, Access, and Reputation Strategy Lead at Roche Slovenija. With an extensive career spanning over a decade, Petra has made significant contributions to the healthcare sector, particularly in drug development and corporate affairs. Her career journey at Roche Slovenija began in various capacities within marketing and sales, where she honed her expertise in business development and strategy. This accumulation of experience has positioned her as a key player in advocating for policy changes and improving patient access to essential medications.

    Before becoming the Policy, Access, and Reputation Strategy Lead, Petra served as the Head of Corporate Affairs, where she successfully managed relationships and communications with key stakeholders in the healthcare landscape. Her prior experience as Head of Business Development further solidified her skills in strategic planning and partnership development, allowing her to drive innovative solutions that meet the evolving needs of patients and healthcare providers.

    Petra's career trajectory also includes pivotal roles where she demonstrated her leadership capabilities and profound understanding of the pharmaceutical domain. As a Business Unit Manager at Roche Slovenija, she was instrumental in overseeing specific product lines, implementing marketing strategies, and nurturing cross-functional collaboration to ensure business growth. Her early career experience at LEK Pharmaceutical Company—which included her role as a researcher focusing on drug stability—provided her with foundational knowledge that continues to inform her strategic decisions in her current role.

    Education and Achievements

    Petra Rupar's academic credentials include a Master of Science degree in Pharmacy from the prestigious University of Ljubljana. This strong educational background laid the foundation for her career in the pharmaceutical sector and equipped her with the necessary skills to address complex challenges related to drug development and regulatory compliance.

    During her time at the University of Ljubljana, Petra was recognized for her commitment to research and academic achievement, serving as a "Mladi raziskovalec" (Young Researcher) at the Faculty of Pharmacy. This role underscored her dedication to advancing pharmaceutical sciences and contributed to her understanding of research methodologies, regulatory frameworks, and therapeutic innovations.

    Achievements

    Throughout her career, Petra Rupar has been actively involved in numerous projects and initiatives aimed at improving healthcare delivery. Her strategic approach to policy and access has led to significant advancements in how pharmaceuticals are perceived and accessed within Slovenia. Petra's efforts in advocacy have been crucial in navigating the complexities of healthcare legislation, ensuring that patients receive timely access to groundbreaking treatments.

    Petra has cultivated a reputation for being both a knowledgeable and approachable leader in her field. She has effectively engaged with healthcare professionals, regulatory bodies, and patient advocacy groups to foster collaborative efforts that contribute to improved health outcomes in Slovenia. Her work not only reflects her personal commitment to the field but also highlights her dedication to enhancing the overall well-being of communities through responsible pharmaceutical practices.

    Related Questions

    What inspired Petra Rupar to transition from a clinical pharmacist to corporate affairs in the pharmaceutical industry?
    How has Petra Rupar's background in pharmacy influenced her strategic decisions in her role at Roche Slovenia?
    In what ways has Petra Rupar contributed to advancements in healthcare policy and access in Slovenia?
    What are some specific initiatives led by Petra Rupar that have positively impacted patient access to medications?
    How does Petra Rupar advocate for the importance of research within the pharmaceutical industry, based on her experiences in academia?
    Petra Rupar
    Add to my network

    Location

    Slovenia